The Treatment of Ascites by Side to Side Portacaval Shunt

Intractable Ascites Management: The Role of Side-to-Side Portacaval Shunt

(1997) Experimental, clinical and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.

Assessment of Portal and Hepatic Hemodynamics after Side-to-side Portacaval Shunt in Patients with Cirrhosis.

Improved quality of life after distal splenorenal shunt. A prospective comparison with side-to-side portacaval shunt.

The distal splenorenal shunt (DSRS) was compared with the side-to-side portacaval shunt (PCS) in 93 prospectively matched patients with portal hypertension. After 38 months mean follow-up the two shunts had a different incidence of acute encephalopathy (22% in PCS group and 33% in DSRS group) and chronic encephalopathy (35% in PCS group and 17% in DSRS group), but the difference was not statist...

A modified microsurgical model for end-to-side selective portacaval shunt in the rat. Intraoperative microcirculatory investigations.

PURPOSE To investigate the intraoperative microcirculatory changes of the affected organs (small bowel, liver and kidney) during the making of a modified selective portacaval (PC) shunt. METHODS On ten anaesthetized Sprague-Dawley rats the selective end-to-side mesocaval anastomosis was performed, where only the rostral mesenteric vein is utilized and the portal vein with the splenic vein are...

Portacaval shunt and hyperlipidemia.

It has been more than four years since completely diverting portacaval shunt was first performed clinically' for the purpose of lowering the serum concentration of cholesterol and low-density lipoproteins (LDL). Since then, we have treated two more patients with this method. An additional nine patients who have undergone the same procedure in other centers have been documented in the literature...